Literature DB >> 27508016

T helper 17 and T helper 1 cells are increased but regulatory T cells are decreased in subchondral bone marrow microenvironment of patients with rheumatoid arthritis.

Ting Wang1, Shufeng Li2, Yun Yang2, Kaining Zhang2, Shixiao Dong3, Xiuhua Wang4, Xinguang Liu5, Yanjun Ren2, Ming Zhang2, Xinfeng Yan2, Jianmin Li6, Lei Zhang2.   

Abstract

OBJECTIVES: The present study is to investigate the profiles of Th17, Th1 and Treg cells in bone marrow of patients with rheumatoid arthritis (RA).
METHODS: Flow cytometry was used to analyze the frequencies of Th17, Th1 and Treg cells in paired peripheral blood and bone marrow of 26 RA patients and 11 osteoarthritis (OA) patients, as well as 10 healthy controls. In addition, the disease activity was analyzed by the 28-joint disease activity score (DAS28).
RESULTS: The frequencies of Th17 and Th1 cells were significantly elevated in bone marrow of RA patients. Importantly, Th17 and Th1 cells were significantly elevated in bone marrow compared with the matched peripheral blood from RA patients. However, Treg cells were significantly decreased in bone marrow of RA patients compared with the matched peripheral blood of RA patients and bone marrow of osteoarthritis patients and healthy controls. Moreover, the frequencies of tumor necrosis factor-α-producing T cells were significantly elevated in bone marrow from RA patients. Additionally, Th17 and Th1 cells in bone marrow were positively correlated with DAS28, while Treg cells were negatively correlated with DAS28.
CONCLUSIONS: The present study demonstrates that Th17 and Th1 cells are markedly increased in bone marrow from RA patients. By contrast, Treg cells are significantly decreased in bone marrow from RA patients. These results suggest that local abnormality of Th17, Th1 and Treg cells in bone marrow of RA patients may contribute to bone destruction in skeletal system.

Entities:  

Keywords:  Rheumatoid arthritis; T helper 1 cells; T helper 17 cells; bone marrow; regulatory T cells

Year:  2016        PMID: 27508016      PMCID: PMC4969432     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  48 in total

1.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

2.  Bone marrow Th17 TNFα cells induce osteoclast differentiation, and link bone destruction to IBD.

Authors:  Thomas Ciucci; Lidia Ibáñez; Agathe Boucoiran; Eléonore Birgy-Barelli; Jérôme Pène; Grazia Abou-Ezzi; Nadia Arab; Matthieu Rouleau; Xavier Hébuterne; Hans Yssel; Claudine Blin-Wakkach; Abdelilah Wakkach
Journal:  Gut       Date:  2014-10-08       Impact factor: 23.059

3.  IL-17/Th17 mediated synovial inflammation is IL-22 independent.

Authors:  Jan Piet van Hamburg; Odilia B J Corneth; Sandra M J Paulissen; Nadine Davelaar; Patrick S Asmawidjaja; Adriana M C Mus; Erik Lubberts
Journal:  Ann Rheum Dis       Date:  2013-01-17       Impact factor: 19.103

4.  Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis.

Authors:  Noriko Komatsu; Kazuo Okamoto; Shinichiro Sawa; Tomoki Nakashima; Masatsugu Oh-hora; Tatsuhiko Kodama; Sakae Tanaka; Jeffrey A Bluestone; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2013-12-22       Impact factor: 53.440

Review 5.  CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.

Authors:  Xavier Valencia; Peter E Lipsky
Journal:  Nat Clin Pract Rheumatol       Date:  2007-11

6.  Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis.

Authors:  Hong Nie; Yingxia Zheng; Runsheng Li; Taylor B Guo; Dongyi He; Lei Fang; Xuebin Liu; Lianbo Xiao; Xi Chen; Bing Wan; Y Eugene Chin; Jingwu Z Zhang
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

7.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.

Authors:  Kojiro Sato; Ayako Suematsu; Kazuo Okamoto; Akira Yamaguchi; Yasuyuki Morishita; Yuho Kadono; Sakae Tanaka; Tatsuhiko Kodama; Shizuo Akira; Yoichiro Iwakura; Daniel J Cua; Hiroshi Takayanagi
Journal:  J Exp Med       Date:  2006-11-06       Impact factor: 14.307

8.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

9.  Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

Authors:  M K Levings; R Sangregorio; M G Roncarolo
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

View more
  6 in total

Review 1.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

2.  [Mechanism of Xiaowugui decoction for treating collagen-induced arthritis in mice].

Authors:  Wenjun Shan; Xiaoyu Zhu; Jieying Qi; Fang Hu; Changzheng Li; Xiaoli Nie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

3.  Analysis of Sodium Chloride Intake and Treg/Th17 Lymphocytes in Healthy Individuals and Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus.

Authors:  Marlen Vitales-Noyola; Esther Layseca-Espinosa; Lourdes Baranda; Carlos Abud-Mendoza; Perla Niño-Moreno; Adriana Monsiváis-Urenda; Yvonne Rosenstein; Roberto González-Amaro
Journal:  J Immunol Res       Date:  2018-07-09       Impact factor: 4.818

4.  Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells.

Authors:  Hongyan Zhao; Huihui Xu; Zhengyun Zuo; Gui Wang; Meijie Liu; Minghui Guo; Cheng Xiao
Journal:  Front Pharmacol       Date:  2018-03-27       Impact factor: 5.810

5.  CD4+FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired.

Authors:  Magdalena Massalska; Anna Radzikowska; Ewa Kuca-Warnawin; Magdalena Plebanczyk; Monika Prochorec-Sobieszek; Urszula Skalska; Weronika Kurowska; Pawel Maldyk; Ewa Kontny; Hans-Jürgen Gober; Wlodzimierz Maslinski
Journal:  Cells       Date:  2020-02-26       Impact factor: 6.600

6.  Elevated Expression of the Long Noncoding RNA IFNG-AS1 in the Peripheral Blood from Patients with Rheumatoid Arthritis.

Authors:  Huiyong Peng; Shuting Ren; Yingzhao Liu; Huimin Zhou; Xinyi Tang; Jun Yang; Jie Tian; Ping Xu; Huaxi Xu; Shengjun Wang
Journal:  J Immunol Res       Date:  2020-01-30       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.